ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

December 5, 2014

Funding Opportunities.

April 19, 2002

St. Jude Offers Three Fellowships

May 3, 1985

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013